Acute pancreatitis severity, in addition to subcutaneous fat area and baseline C-reactive protein, can help predict diabetes in youth.
Overall survival at 5 years for individuals who received a liver transplant for certain cancers is deemed adequate.
During pregnancy, women should receive recommended COVID-19 vaccines to protect themselves, as well as their young infants.
Casirivimab and imdevimab in combination is safe among pediatric outpatients with at least 1 risk factor for severe COVID-19.
The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist obesity medications.
An algorithm can identify individuals with MASLD with 88 percent accuracy using electronic medical record (EMR) data.
Palliative care is associated with a reduction in inpatient procedures in terminal hospitalizations for patients with hepatocellular carcinoma (HCC), according to study results published in the ...
Remdesivir plus dexamethasone vs dexamethasone alone reduces the risk of mortality among patients hospitalized with COVID-19.
Racism and health are intertwined such that people with HIV living in historically redlined neighborhoods may experience a longer time to viral suppression.
The FDA has approved Yesintek (Ustekinumab-kfce), a biosimilar to Stelara (Ustekinumab), for the treatment of various chronic inflammatory diseases.
Firearm injury-related emergency department visit rates increased from 2018 to 2020, then decreased through 2023.
Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness.